Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
EyePoint, Inc. - Common Stock
(NQ:
EYPT
)
5.050
+0.045 (+0.90%)
Streaming Delayed Price
Updated: 1:54 PM EDT, Aug 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about EyePoint, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Shares Drop on Q3 Earnings and Revenue Miss
↗
November 05, 2025
EyePoint Pharmaceuticals stock falls after Q3 2025 earnings miss estimates. Despite the financial setback, its key DURAVYU trials for wet AMD are fully enrolled and on track for 2026 data.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 15, 2025
Via
Benzinga
EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study
↗
October 15, 2025
EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding.
Via
Benzinga
EyePoint (EYPT) Q2 Revenue Drops 44%
↗
August 06, 2025
Via
The Motley Fool
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Analyst Expectations For EyePoint Pharmaceuticals's Future
↗
May 29, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
A Peek at EyePoint Pharmaceuticals's Future Earnings
↗
May 06, 2025
Via
Benzinga
Demystifying EyePoint Pharmaceuticals: Insights From 4 Analyst Reviews
↗
March 06, 2025
Via
Benzinga
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Q2 2025 Earnings Miss Estimates as Shares Drop 4.5% Pre-Market
↗
August 06, 2025
EyePoint Pharmaceuticals (EYPT) Q2 2025 earnings miss estimates with $5.33M revenue and -$0.85 EPS, sparking a 4.5% pre-market drop. Clinical progress in DURAVYU Phase 3 trial offers hope amid...
Via
Chartmill
Topics
Earnings
Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals
↗
June 17, 2025
Via
Benzinga
Breakout Momentum Plays You May Not Know About
June 06, 2025
Momentum investing is all about timing—these three under-the-radar stocks have begun to rise by still seem to have room for further growth.
Via
MarketBeat
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
↗
May 28, 2025
Via
Benzinga
Analyst Ratings For EyePoint Pharmaceuticals
↗
October 25, 2024
Via
Benzinga
EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
↗
August 13, 2024
Via
Benzinga
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Earnings Scheduled For March 5, 2025
↗
March 05, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
February 18, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
↗
February 05, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 28, 2024
Via
Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
↗
October 28, 2024
EyePoint Pharmaceuticals' shares rise as interim Phase 2 VERONA trial data shows Duravyu improves visual acuity and anatomy in diabetic macular edema patients.
Via
Benzinga
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
October 28, 2024
Via
Benzinga
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
↗
October 14, 2024
Via
Benzinga
Topics
Government
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
July 12, 2024
Via
Benzinga
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
↗
July 12, 2024
Via
Benzinga
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
↗
May 13, 2024
Via
Benzinga
EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
↗
May 08, 2024
EYPT stock results show that EyePoint Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
May 08, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
